Other Sources of Funding

Broad Medical Research Program

The Eli and Edythe Broad Foundation, through the BMRP, provides 40 percent of all private funding for IBD research in the United States.  Their approach is different than many traditional scientific and medical funding organizations.  They fund early stage investigation – with the goal that innovative ideas need financial support for early testing to ultimately lead to effective treatment, diagnosis and prevention of IBD.

The BMRP provides rapid funding to investigators working in non-profit organizations worldwide for up to two years for basic or clinical IBD research projects that:

• Are innovative
• Are in the early stages of exploration
• Will improve the diagnosis, therapy or prevention of IBD in the near future; and
• Will lead to longer-term funding by more traditional granting agencies

The BMRP provides funding to generate pilot research data, rather than serving as the final grant source for a research project. Grantees are encouraged to generate sufficient preliminary data in the first year in order to compete successfully for continuation funding from us and/or other sources.

The Kenneth Rainin Foundation

The Kenneth Rainin Foundation believes that finding causes and cures for Inflammatory Bowel Disease (IBD) will require bold and creative ideas that expand our ability to further explore and conquer these challenges.

To accelerate the pace of discovery in IBD research, the Foundation is launching a new award, the Kenneth Rainin Foundation Innovator Awards Program for IBD Research.

Read more.


National Institutes of Health (NIH)

The National Institutes of Health (NIH) conduct and support biomedical research, disseminating research findings and health information to the public. NIH is part of the U.S. Government, under the Department of Health and Human Services (HHS). Two main institutes at NIH, the National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute for Allergies and Infectious Diseases (NIAID), provide funding for IBD-related research.

Grants in Aid of Research
The CCFC Grants in Aid of Research program is intended to support research on inflammatory bowel disease (IBD). Grants are awarded to investigators working alone or in collaboration with others. Grants will be awarded for a maximum of three years, not to exceed $125,000 per annum.

The CCFC Visiting Scientist Program
The CCFC Visiting Scientist program is designed to allow Canadian institutions to bring in productive scientists having expertise not available within the institution, and to allow Canadian scientists to visit major international research centers in order to acquire knowledge or new techniques related to IBD research.

"Innovations in IBD Research": A Special Competition
The Crohn's and Colitis Foundation of Canada invites applications for an "Innovations Grant", to fund novel or innovative approaches to IBD research. This grant is intended to stimulate and support research which may not be encompassed within the boundaries of traditional medical research. Research proposals must conform to sound principles of research and may aim to collect pilot data for follow-on application(s). The Foundation seeks mission relevance and excellence as well as innovation.

CCFC Strategic Priority Partnership Initiative
To address priorities outlined in the current strategic plan, the CCFC is inviting proposals which include partnering financial supporter(s) and focus on clinical/translational, epidemiological and/or health service questions relevant to IBD. To augment the historical emphasis on basic science and biomedical research ("Pillar I research" as defined by CIHR), the CCFC strategic plan prioritizes a diversification of research investment. Doing so in partnership with other organizations with common interest in particular questions which are able to co-fund projects will help make this possible. Two examples of potential partners would include provinces in need of better prevalence estimates for IBD and organizations interested in sponsoring clinical/translational research that requires funding at levels exceeding the capacity of current CCFC programs.

Partnerships may be negotiated and described in a cover letter with other supporting documentation appended to a full proposal using the 2010 GIA application form available above. To provide applicants additional time needed to work on partnership details, the deadline for this competition will be Monday, December 14th, 2009 (This later deadline is only for those proposals which will have partner funding and would not be classified as Pillar I research).

Applications received through this partnership initiative will be reviewed along with those submitted for the yearly GIA competition in the Spring of 2010. Final positive decisions regarding funding any such partnership project(s) will be contingent on scientific merit, relevance to the mission of the CCFC, fit with strategic priorities of the CCFC and partner funding at a minimum of 50% of the total project budget. While final decisions regarding co-funding from partners need not be in place when proposals are submitted, funding from the CCFC will not be approved until matching (or better) dollars are committed by the partner(s). The maximum amount of co-funding from the CCFC for this partnership initiative is $125,000 per year for up to three years (same as GIA program).

updated 4/5/10